Article
<i>PDGRFA</i>-mutant gastrointestinal stromal tumours (GISTs) in Eastern England: clinicopathological features and outcomes of 50 patients diagnosed between 2008-2021
2021-12-27
Abstract excerpt
<h4>Background</h4> PDGRFA -mutant gastrointestinal tumours (GISTs) comprise approximately 10% of GISTs and are mostly gastric. Targeted therapies against these tumours have historically been limited by tyrosine kinase inhibitor (TKI)-resistance. We reviewed the characteristics and outcome of all PDGRFA -mutant patients seen at our centre over the last 13 years. <h4>Methods</h4> All PDGRFA -mutant patients seen at...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 728bf01c-c693-5cce-a157-def7a68219d7
- DOI
- 10.1101/2021.12.24.21268386
